Vitamin E supplementation in the prevention of coronary heart disease

Mayo Clinic Proceedings

Volumn 76, Issue 11, 2001, Pages 1131-1136

  Pruthi, Sandhya ^a   Allison, Thomas G ^a   Hensrud, Donald D ^a  

^a MAYO CLINIC   (United States)

Author keywords

ATBC = alpha tocopherol, beta carotene cancer prevention; CHAOS = cambridge heart antioxidant study; CHD = coronary heart disease; GISSI = gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico; HOPE = heart outcomes prevention evaluation; LDL = low density lipoprotein; PPP = primary prevention project; PUFA = polyunsaturated fatty acid

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TOCOPHEROL;

ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; FATIGUE; FRUIT; HUMAN; ISCHEMIC HEART DISEASE; MUSCLE WEAKNESS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SECONDARY PREVENTION; VEGETABLE; VITAMIN SUPPLEMENTATION;

EID: 0034766047     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.11.1131     Document Type: Review

References (40)

1. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination
2. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
4. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
5. Antioxidant nutrients and disease prevention: An overview
6. Action of ascorbic acid as a scavenger of active and stable oxygen radicals
7. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
8. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
9. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: Dose response to vitamin E supplementation
10. The effect of α-tocopherol supplementation on LDL oxidation: A dose-response study
11. Vitamin E consumption and the risk of coronary heart disease in men
12. Vitamin E consumption and the risk of coronary disease in women
13. Analysis and distribution of vitamin E in vegetable oils and foods
14. Vitamin therapy in the absence of obvious deficiency: What is the evidence?
15. Safety of oral intake of vitamin E
16. Marcus Fl Coagulopathy associated with vitamin E ingestion
17. α-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
18. On the mechanism of the anticlotting action of vitamin E quinone
19. Proposed study of vitamin E therapy
20. A double-blind trial of vitamin E in angina pectoris
21. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
22. Antioxidant status, fatty acids, and cardiovascular disease
23. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly
24. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
25. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
26. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
27. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
28. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: Rationale, design, and methods
29. Design of physicians' health study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
30. MRC/BHF heart protection study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: Early safety and efficacy experience
31. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease
32. Prostate cancer and supplementation with α-tocopherol and β-carotene: Incidence and mortality in a controlled trial
33. Vitamin/mineral supplementation, the aging immune response, and risk of infection
34. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: A randomized controlled trial
35. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E and β-carotene: A statement for healthcare professionals from the American Heart Association